Multimodality therapy for pancreatic can
โ
Karl Y. Bilimoria; David J. Bentrem; Clifford Y. Ko; James S. Tomlinson; Andrew
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 164 KB
## Abstract ## BACKGROUND. Despite decreased perioperative morbidity and mortality and clinical trials suggesting improved outcomes with adjuvant therapy, national practice patterns in the management of pancreatic cancer remain poorly defined. The purpose of the current study was to evaluate multi